Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Notes Payables (2016 - 2025)

National Research's Notes Payables history spans 16 years, with the latest figure at $4.0 million for Q4 2025.

  • For Q4 2025, Notes Payables fell 16.18% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $4.0 million, down 16.18%, while the annual FY2025 figure was $4.0 million, 16.18% down from the prior year.
  • Notes Payables for Q4 2025 was $4.0 million at National Research, roughly flat from $4.0 million in the prior quarter.
  • Across five years, Notes Payables topped out at $7.6 million in Q2 2024 and bottomed at $3.0 million in Q1 2025.
  • The 5-year median for Notes Payables is $4.4 million (2022), against an average of $4.7 million.
  • The largest annual shift saw Notes Payables soared 65.07% in 2024 before it plummeted 59.54% in 2025.
  • A 5-year view of Notes Payables shows it stood at $4.3 million in 2021, then increased by 4.98% to $4.5 million in 2022, then skyrocketed by 60.63% to $7.2 million in 2023, then plummeted by 33.62% to $4.8 million in 2024, then decreased by 16.18% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for NRC's Notes Payables are $4.0 million (Q4 2025), $4.0 million (Q3 2025), and $3.9 million (Q2 2025).